New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
08:27 EDTIMUCImmunoCellular upgraded to Buy from Neutral at Roth Capital
News For IMUC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 19, 2015
09:20 EDTIMUCOn The Fly: Pre-market Movers
Subscribe for More Information
06:12 EDTIMUCImmunoCellular signs manufacturing agreement with Pharmacell B.V.
ImmunoCellular established an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma. This agreement with PharmaCell, a European contract manufacturing organization, focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use